In colon cancer, PGE2 derived through COX-2 has been shown to lead to a feed forward mechanism, in which receptor-interacting protein kinase 3 (RIPK3) results in activation of myeloid suppressor cells and suppression of anti-tumor immunity (Yan et al., 2018). Here, RIPK3 is linked to neoplasm.